Patents by Inventor Erwin Soutscheck

Erwin Soutscheck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090098528
    Abstract: The present invention concerns a polypeptide which is composed of the amino acids 1207±10 to 1488±10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.
    Type: Application
    Filed: October 11, 2007
    Publication date: April 16, 2009
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Urban Schmitt, Manfred Motz, Michael Wiedmann, Barbara Upmeier, Erwin Soutscheck
  • Patent number: 7083792
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: August 1, 2006
    Assignee: Mikrogen Molekularbiologische Entwicklungs - GmbH
    Inventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
  • Publication number: 20040253611
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Application
    Filed: January 22, 2004
    Publication date: December 16, 2004
    Applicant: Mikrogen Molekularbiologische Entwicklungs-GmbH
    Inventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
  • Patent number: 6753183
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Grant
    Filed: November 7, 2002
    Date of Patent: June 22, 2004
    Assignee: Mikrogen Molekularbiologische Entwicklungs-GmbH
    Inventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
  • Publication number: 20030157562
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Application
    Filed: November 7, 2002
    Publication date: August 21, 2003
    Applicant: Mikrogen Molekularbiologische Entwicklungs-GmbH
    Inventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
  • Patent number: 6509019
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: January 21, 2003
    Assignee: Mikrogen Molekularbiologische Entwicklungs-GmbH
    Inventors: Renate Fuchs, Bettina Wilske, Vera Preac-Mursic, Manfred Motz, Erwin Soutscheck
  • Patent number: 6248538
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Grant
    Filed: March 10, 1994
    Date of Patent: June 19, 2001
    Assignee: Mikrogen Molekularbiogische Entwicklungs - GmbH
    Inventors: Manfred Motz, Erwin Soutscheck, Renate Fuchs, Bettina Wilske, Vera Preac-Mursic
  • Patent number: 6183755
    Abstract: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation.
    Type: Grant
    Filed: November 19, 1998
    Date of Patent: February 6, 2001
    Assignee: Mikrogen Molekularbiologische Entwicklungs- GmbH
    Inventors: Manfred Motz, Erwin Soutscheck, Renate Fuchs, Bettina Wilske, Vera Preac-Mursic